Pharmaceuticals

Parathyroid Hormone Market Insights On Growth Drivers, Trends, And Opportunities

May 1, 2026May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Parathyroid Hormone Market Over The 2026–2030 Period?

The parathyroid hormone market size has experienced substantial expansion over recent years. Projections indicate it will expand from $2.51 billion in 2025 to $2.8 billion by 2026, registering a compound annual growth rate (CAGR) of 11.5%. Historically, this expansion was driven by factors such as the limited availability of recombinant parathyroid hormone, low disease awareness among patients, reliance on conventional vitamin D therapy, expanding hospital and clinic infrastructure, and an increase in post-surgical parathyroid complications.

The market for parathyroid hormone is anticipated to experience significant expansion in the coming years. This market is projected to reach $4.4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.9%. This projected growth is driven by several factors, including the creation of sophisticated parathyroid hormone analogues, the increasing implementation of personalized medicine strategies, the establishment of more hospitals and specialized clinics, the incorporation of digital tools for patient monitoring, and intensified governmental and healthcare efforts aimed at addressing hypocalcemia and hypoparathyroidism. Key trends expected during this period encompass the growing occurrence of hypocalcemia and hypoparathyroidism, a rise in the application of recombinant parathyroid hormone treatments, an increase in parathyroid hormone analogues designed for individualized patient care, the broadening of parathyroid care programs within hospitals and clinics, and an increased emphasis on post-surgical patient management along with vitamin D supplementation.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp

Which Drivers Are Supporting The Parathyroid Hormone Market Growth?

The growing number of older adults is anticipated to drive expansion in the parathyroid hormone market in the future. This demographic, consisting of individuals generally 65 years and above, often faces health issues associated with aging and necessitates specific medical attention and assistance. This societal change stems from longer lifespans, improved medical care, and lower birth rates, leading to a greater percentage of older people within the population. Parathyroid hormone plays a crucial role for the elderly by managing calcium levels and bone metabolism, thereby aiding in the prevention of osteoporosis and bone fractures, conditions frequently observed in older individuals. As an illustration, data from January 2024, provided by the US-based nonprofit Population Reference Bureau, projects the American population aged 65 and above to increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Concurrently, this age cohort’s proportion of the total population is also forecast to expand from 17% to 23% within the identical timeframe. Consequently, the expanding elderly demographic is fueling the growth of the parathyroid hormone market.

What Are The Key Segment Divisions In The Parathyroid Hormone Market Segment Structure?

The parathyroid hormone market covered in this report is segmented –

1) By Disease Type: Hypocalcemia, Hypoparathyroidism

2) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Hypocalcemia: Pseudohypoparathyroidism, Vitamin D Deficiency

2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism, Idiopathic Hypoparathyroidism

What Trends Are Transforming The Parathyroid Hormone Market?

Leading companies active in the parathyroid hormone market are concentrating on developing biosimilar versions of parathyroid-based medications, such as prodrugs of parathyroid hormone (PTH), to enhance available treatment options. A parathyroid hormone (PTH) prodrug is an inactive compound that transforms into active parathyroid hormone following administration, allowing for prolonged release and stable therapeutic outcomes for calcium regulation and bone health. For instance, in August 2024, Ascendis Pharma A/S, a biopharmaceutical company headquartered in Denmark, announced that the Food & Drug Administration (FDA) approved YORVIPATH (palopegteriparatide) as the initial and sole treatment for hypoparathyroidism in adults. This once-daily prodrug ensures continuous exposure to PTH, benefiting an estimated 70,000 to 90,000 patients in the United States. Ascendis Pharma, the manufacturer, provides patient support through its ascendis signature access program (A.S.A.P.) program, but individuals must regularly monitor serum calcium levels for potential hypercalcemia or hypocalcemia.

Which Organizations Are Engaged In The Parathyroid Hormone Market?

Major companies operating in the parathyroid hormone market are Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Wockhardt, Cipla Limited

Get The Full Parathyroid Hormone Market Report:

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Which Region Accounts For The Largest Portion Of The Parathyroid Hormone Market?

North America was the largest region in the parathyroid hormone market in 2025. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Parathyroid Hormone Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Browse Through More Reports Similar to the Global Parathyroid Hormone Market 2026, By The Business Research Company

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Drugs For Hormonal Replacement Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Thyroid Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795